- September 28, 2026
This fund that lets retail traders invest in SpaceX and OpenAI is trading at a massive premium
[ad_1] A new fund designed to give retail investors a way to buy into private companies like SpaceX has seen huge demand in its first
To outsource or not to outsource? Buy-side heads of trading discuss at TradeTech 2024
[ad_1] Two heads of trading desk invited to speak on stage at TradeTech 2024 were posed with a bombshell question at the end of their
‘Buy before build’ says UBS AM’s global trading head Lynn Challenger
[ad_1] When asked to assess how to ensure future resilience in an ever-changing market, Lynn Challenger, global head of trading and order generation at UBS
Traders build up bets of Fed interest rate rise
[ad_1] Stay informed with free updates Simply sign up to the World myFT Digest — delivered directly to your inbox. Good morning. Traders have built
Binance’s Rivals Muscle In on Bitcoin (BTC) Trading Around the World
[ad_1] Crypto exchanges are eating into Binance’s share of Bitcoin trading outside the US as overseas expansion efforts and changing regulations reshape the competitive dynamics
NYSE Considers 24/7 Trading to Share the Stars with Crypto
[ad_1] Old School Wall Street is considering ’round-the-clock, or 24/7 trading, to prevent crypto from getting a leg up on it. Unlike traditional stock markets,
China Finance Ministry Echoes Xi’s Call for Bond Trading at PBOC
[ad_1] (Bloomberg) — China’s Ministry of Finance said it supports allowing the central bank to trade government bonds, reaffirming a sentence from President Xi Jinping
John Lynch Says the 49ers Might Consider Trading Out of Round 1
[ad_1] SANTA CLARA — John Lynch was asked on Monday if he would consider trading down from pick 31 in the upcoming draft. Here’s what
Stocks rebound, AI in Big Tech, Tesla: Trading Takeaways
[ad_1] After a tumultuous start to the second quarter, stock market indices (^DJI, ^IXIC, ^GSPC) are seeing a solid day of green to kick off
Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday?
[ad_1] Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday? Friday, Hepion Pharmaceuticals Inc. (NASDAQ:HEPA) said it has begun winding down activities in its